Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5 (Q64378863)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Xin-Yuan Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Song-Bo Qiu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Wei-Gou Zou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Zi-Fei Pei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jin-Fa Gu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Chun-Xia Luo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hong-Mei Ruan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Yu Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Yi-Peng Qi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Cheng Qian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

531-541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Combination of Targeting Gene-ViroTherapy with 5-FU enhances antitumor efficacy in malignant colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Identification and characterization of a new member of the TNF family that induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Safety and antitumor activity of recombinant soluble Apo2 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Angiogenesis in cancer and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Gene therapy strategies for tumor antiangiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Kringle 5 of Plasminogen is a Novel Inhibitor of Endothelial Cell Growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Reovirus therapy of tumors with activated Ras pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Intergeneric poliovirus recombinants for the treatment of malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

Transcriptional targeting of herpes simplex virus for cell-specific replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2004.12.003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771956%20AND%20SRC:MED&resulttype=core&format=json